Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Claudia Salvini de Almeida"'
Autor:
Diogo Diniz Gomes Bugano, Alexandre Biasi Cavalcanti, Anderson Roman Goncalves, Claudia Salvini de Almeida, Eliézer Silva
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 3, Pp 265-282 (2011)
ABSTRACT Objective: To compare efficacy and safety of vancomycin versus teicoplanin in patients with proven or suspected infection. Methods: Data Sources: Cochrane Renal Group's Specialized Register, CENTRAL, MEDLINE, EMBASE, nephrology textbooks and
Externí odkaz:
https://doaj.org/article/d3d74658b539460e9e1ba1af593e9ce7
Autor:
Alexandre Biasi Cavalcanti, Eliezer Silva, Anderson R.R. Gonçalves, Diogo Diniz Gomes Bugano, Claudia Salvini de Almeida
Publikováno v:
Einstein (São Paulo), Vol 9, Iss 3, Pp 265-282 (2011)
einstein (São Paulo) v.9 n.3 2011
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Einstein (São Paulo), Volume: 9, Issue: 3, Pages: 265-282, Published: SEP 2011
einstein (São Paulo) v.9 n.3 2011
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
Einstein (São Paulo), Volume: 9, Issue: 3, Pages: 265-282, Published: SEP 2011
Objective: To compare efficacy and safety of vancomycin versus teicoplanin in patients with proven or suspected infection. Methods: Data Sources: Cochrane Renal Group's Specialized Register, CENTRAL, MEDLINE, EMBASE, nephrology textbooks and review a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a512753e4c4fdad24af55e5b022719
https://doi.org/10.1590/s1679-45082011ao2020
https://doi.org/10.1590/s1679-45082011ao2020
Autor:
Samuel Katsuyuki Shinjo, Claudia Salvini de Almeida, Márcio Veronesi Fukuda, Simone Chinwa Lo
Publikováno v:
Clinical Rheumatology. 28:301-304
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with various clinical and serological manifestations. Previous studies have shown the association of SLE and anti-Ro antibody with a series of clinical manifestations. We inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3b9dfdce124bc1df54c0c9a9c2ebf5
https://doi.org/10.1007/s10067-008-1043-5
https://doi.org/10.1007/s10067-008-1043-5
Autor:
Eliezer Silva, Anderson R.R. Gonçalves, Alexandre Biasi Cavalcanti, Claudia Salvini de Almeida, Diogo Dg Bugano
Publikováno v:
The Cochrane Library
Background Vancomycin and teicoplanin are commonly used to treat gram-positive infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). There is uncertainty regarding the effects of teicoplanin compared to vancomyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c350243d7744c49baf356c4fb82466
https://pubmed.ncbi.nlm.nih.gov/20556772
https://pubmed.ncbi.nlm.nih.gov/20556772